Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2011
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737Keryn M Lucas, Nethia Mohana-Kumaran, Diana Lau, et al.
Carcinogenesis|July 14, 2012
The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cellsHsin-Yi Tseng, Li Hua Chen, Yan Ye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2015
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastasesHojabr Kakavand, Ricardo E Vilain, James S Wilmott, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 4, 2015
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S Wilmott, Andrew J Colebatch, Hojabr Kakavand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanomaJohn M Kirkwood, Paul Lorigan, Peter Hersey, et al.
Cancer|January 29, 2010
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanomaPeter Hersey, Jeffrey Sosman, Steven O'Day, et al.
Molecular Cancer|December 17, 2009
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2Hao Liu, Chen Chen Jiang, Christopher J Lavis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanomaJames S Wilmott, Georgina V Long, Julie R Howle, et al.
Iscience|September 22, 2018
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in MelanomaAniruddha Chatterjee, Euan J Rodger, Antonio Ahn, et al.
The Journal of Investigative Dermatology|October 25, 2021
Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant MelanomaFarzana Ahmed, Hsin-Yi Tseng, Antonio Ahn, et al.
Pageof 16